Gilead Sciences Under Investigation for Over-Charging for Hepatitis C Pill
Gilead Sciences of San Francisco is under investigation by the U.S. Senate Finance Committee for charging $84,000 for a 12 week course of a new drug to treat hepatitis C. Gilead sells the exact same course for $900 in poor countries like Egypt and India.
Join the discussion below, or Read more at CorpWatch.
#1 Jul 21, 2014
Of course to get good drugs developed, profit has to be the incentive. The price of this drug is cheaper than the alternatives. If my insurance co declined to pay for it, I would sue. Plus people without insurance or money get the price subsidized, so all of this complaining is only to benefit insurance co profits
Add your comments below
|EU court: Vaccines can be blamed for illnesses ...||Wed||RIGHT ON||2|
|Burlington dental patients told to get tested f...||Wed||Lenny||1|
|The opioid epidemic is making the fight against...||Jun 14||Ronald||2|
|Should state mandate immunizations? New require... (May '11)||May 31||questions Please||9,769|
|Finally! UK Government expected to make it easi...||May '17||Gremlin||2|
|Hepatitis C: Down but Not Out - Oral Direct-Act...||Mar '17||hcvnewdrugs||1|
|Syringe exchange called for in Pittsfield||Mar '17||pissed off and on||4|
Find what you want!
Search Hepatitis Forum Now
Copyright © 2017 Topix LLC